evertex fabrinology limited

TWSE:1470 Stok Raporu

Piyasa değeri: NT$1.7b

evertex fabrinology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

evertex fabrinology şirketinin kazançları yıllık ortalama -2.8% oranında azalırken, Luxury sektörünün kazançları yıllık 9.3% oranında artan oldu. Gelirler yıllık ortalama 2.1% oranında azalan oldu. evertex fabrinology şirketinin öz sermaye getirisi 6.6% olup, net marjı 9.4% dir.

Anahtar bilgiler

-2.8%

Kazanç büyüme oranı

-2.7%

EPS büyüme oranı

Luxury Sektör Büyümesi8.2%
Gelir büyüme oranı-2.1%
Özkaynak getirisi6.6%
Net Marj9.4%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Recent updates

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Gelir ve Gider Dağılımı

evertex fabrinology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TWSE:1470 Gelir, gider ve kazançlar (TWD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24702661060
30 Jun 24651601010
31 Mar 2461345940
31 Dec 2365549960
30 Sep 2363749920
30 Jun 2371756970
31 Mar 23777411000
31 Dec 22845331060
30 Sep 22951501080
30 Jun 22968501130
31 Mar 22993861200
31 Dec 21895651130
30 Sep 21858671150
30 Jun 21773631070
31 Mar 2162625920
31 Dec 2063135960
30 Sep 20647321050
30 Jun 20695401130
31 Mar 20815721260
31 Dec 19818761280
30 Sep 19814791240
30 Jun 19802771220
31 Mar 19792621210
31 Dec 18754491160
30 Sep 18735471140
30 Jun 18704361110
31 Mar 18693401110
31 Dec 17701421130
30 Sep 17711421150
30 Jun 17703391140
31 Mar 17682401100
31 Dec 16686471070
30 Sep 16687501030
30 Jun 16713641000
31 Mar 1674562980
31 Dec 1576261980
30 Sep 1577063990
30 Jun 1574754970
31 Mar 1574362950
31 Dec 1474466880
30 Sep 1473857830
30 Jun 1474858800
31 Mar 1470742750
31 Dec 1366929730

Kaliteli Kazançlar: 1470 büyük bir tek seferlik kazanç ile NT$14.8M, 30th September, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: 1470 'nin mevcut net kar marjları (9.4%) geçen yılın (7.7%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 1470 şirketinin kazançları son 5 yılda yılda 2.8% oranında azaldı.

Büyüme Hızlandırma: 1470 'un son bir yıldaki kazanç büyümesi ( 35.2% ) 5 yıllık ortalamasını (yıllık -2.8% ) aşıyor.

Kazançlar vs. Sektör: 1470 geçen yılki kazanç büyümesi ( 35.2% ) Luxury sektörünün 13.9% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: 1470 'nin Özsermaye Getirisi ( 6.6% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin